Cyclophosphamide. Cyclophosphamide (Cytoxan), an immunosuppressive agent, may be effective for preventing lung deterioration and is the important agent for treating pulmonary fibrosis. Cyclophosphamide, available in forms that are intravenous and taken by mouth, blocks some of the destructive actions of scleroderma in the lung. Intravenous cyclophosphamide can be life-saving for patients with pneumonia resulting from interstitial lung disease. Si...
Read more »Probably one of the biggest issues faced by people with COPD is loss; the loss of their former... Read more »
When we're looking at Migraine and headache information, whether it's from our doctor, a book, or... Read more »
Diabetes is not one disease and different types of diabetes have been identified in the scientific... Read more »
Very often, medicine is very territorial. You have this vast field subdivided into subspecialties... Read more »
“Why Me?” Just last week one of my patients was in the office asking this important... Read more »
(Ivanhoe Newswire) -- There are a few endurance athletes for whom regular athletic training will increase the risk of cardiac arrhythmias and even... Read summary »
(Ivanhoe Newswire) -- An antioxidant contained in nutritional supplements often used by body builders has been linked to a serious respiratory... Read summary »
(Ivanhoe Newswire) -- A newer procedure that targets pulmonary veins may be more beneficial to patients with atrial fibrillation than a more... Read summary »
(Ivanhoe Newswire) -- Time is of the essence -- at least for patients with chronic obstructive pulmonary disease (COPD). According to a new study,... Read summary »
(Ivanhoe Newswire) -- New insight into ancient bacteria may spur the development of a novel cystic fibrosis (CF) treatment. People who have CF suffer... Read summary »